Cargando…

519. Multidrug-resistant Gram-Negative Bacteremia in Pediatric Patients: Is It Time to Change to Empiric Meropenem?

BACKGROUND: The rise of antimicrobial resistance among gram-negative (GN) pathogens has been dramatic nationally. Delayed initiation of active antimicrobial agents has been associated with poor outcomes. We aimed at evaluating the prevalence and treatment of multi-drug-resistant gram-negative (MDR-G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mongkolrattanothai, Kanokporn, Stach, Leslie, Orbach, Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810655/ http://dx.doi.org/10.1093/ofid/ofz360.588

Ejemplares similares

477. Characterization of Extended-Spectrum Β-Lactamase (ESBL) Producing Gram-negative (GN) Urinary Tract Infections (UTI) in Pediatric Patients
por: Stach, Leslie, et al.
Publicado: (2019)

2122. Isavuconazonium for Invasive Fungal Therapy: Single-Center Pediatric Experience
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

276. Vancomycin Utilization in a Neonatal Intensive Care Unit
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2018)

2781. The Use of Aminoglycosides for Treatment of Urinary Tract Infections in Pediatric Patients, a Carbapenem-Sparing Approach
por: Legaspi, Jamie, et al.
Publicado: (2023)

1354. Reducing vancomycin utilization rate in a level 4 NICU
por: Chang, Millie R, et al.
Publicado: (2020)

216. A Comparison of Multidrug-Resistant Gram-negative Bacteremia in Cancer and Non-Cancer Patients
por: Haris Khan, Muhammad, et al.
Publicado: (2023)

114. Implementation of an Empiric Organism Specific Guidelines for Gram-negative Bacteremia in conjunction with Rapid Diagnostic Testing
por: Bernice, Fidelia, et al.
Publicado: (2020)

2244. Clinical Outcomes with Extended Infusion (EI) vs. Intermittent Infusion (II) of Cefepime (FEP), Piperacillin/Tazobactam (TZP), and Meropenem (MEM) in Patients with Gram-Negative (GN) Bacteremia
por: Tran, Kieu-Nhi, et al.
Publicado: (2019)

2679. Factors Associated with Multidrug-resistant Gram-Negative Bacteremia in Acute Leukemia Patients with Neutropenic Fever, a Retrospective Study
por: Chaiittiporn, Dudrudee, et al.
Publicado: (2019)

2131. Multicenter Evaluation of Meropenem/Vaborbactam MIC Results for Enterobacteriaceae Using MicroScan Dried Gram-Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2019)

In vitro Activity of Fosfomycin, Alone and Combined with Cefepime and Meropenem, Against Carbapenemase-Producing Gram-Negative Bacteria
por: Wiederhold, Nathan P, et al.
Publicado: (2017)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia
por: Ammar, Mona Ahmed, et al.
Publicado: (2018)

1800. Clinical Impact of Real-Time Predictive Model to Facilitate Antibiotic Prescribing in Gram-Negative Bacteremia
por: Hamilton, Keith W, et al.
Publicado: (2018)

1033. Effectiveness of a Physician-Driven Automated Antibiotic Time Out in the Setting of Gram-negative Bacteremia
por: Mohayya, Sana, et al.
Publicado: (2019)

1359. Activity of Meropenem/Nacubactam Combination Against Gram-Negative Clinical Isolates: ROSCO Global Surveillance 2017
por: Okujava, Rusudan, et al.
Publicado: (2018)

258. A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
por: Nolen, Rebecca C, et al.
Publicado: (2020)

Impact of Persistent Multidrug-Resistant Gram-Negative Bacteremia on Clinical Outcome and Mortality
por: Kitaya, Shiori, et al.
Publicado: (2023)

200. Comparison of Clinical Outcomes among Patients Treated with Ceftriaxone 2 Grams versus 1 Gram Daily for Gram-Negative Bacteremia
por: Huynh-Phan, Ricky, et al.
Publicado: (2023)

Impact of Verigene Multiplex PCR for Positive Blood Cultures and Gram-negative Bacteremia
por: Adams, Matthew, et al.
Publicado: (2017)

1039. Surveillance Blood Cultures Associated With Decreased Mortality in Gram-Negative Bacteremia
por: Maskarinec, Stacey A, et al.
Publicado: (2018)

150. Urinary Tract-Associated Gram-Negative Bacteremia: Impact of Treatment Duration
por: Badwal, Jasmin K, et al.
Publicado: (2019)

149. Short vs. Long Course of Antibiotics for Uncomplicated Gram-Negative Bacteremia
por: Go, James, et al.
Publicado: (2019)

1686. Bacteremia associated with intravascular catheter colonization with Gram-negative rods in children
por: Hisano, Hina, et al.
Publicado: (2023)

177. Infectious Diseases Consultation Associated with Decreased Mortality in Gram-Negative Bacteremia
por: Bruning, Rebecca, et al.
Publicado: (2023)

1253. Optimization of empiric gram-negative infections with the combination antibiogram
por: Leung, Anthony K, et al.
Publicado: (2023)

Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremia
por: Mohayya, Sana M., et al.
Publicado: (2023)

1545. Gram-Negative Bacteremia in Neutropenic Patients: Risk Factors for Mortality in the Era of Multiresistance
por: Herrera, Fabián, et al.
Publicado: (2018)

1044. Aztreonam (AZT) vs. Cephalosporin (CEP) Therapy for the Treatment of Gram-Negative Bacteremia
por: Shah, Sunish, et al.
Publicado: (2018)

188. Which patients with gram-negative bacteremia need follow-up blood cultures?
por: Jung, Jongtak, et al.
Publicado: (2019)

1818. Characteristics Associated with Mortality in Patients with Gram-negative Bacteremia in Intensive Care Units
por: Shukdinas, Alaina, et al.
Publicado: (2022)

231. Blood Neutrophil to Lymphocyte Ratio Is Associated with Mortality And Readmission in Gram Negative Bacteremia
por: Roldgaard, Marcus, et al.
Publicado: (2023)

140. Follow-up Blood Cultures for Gram-Negative Bacteremia among Adults with Cancer
por: Haak, David, et al.
Publicado: (2023)

1022. Is it Time to Re-Evaluate Oral Β-Lactam Antibiotics for Step-Down Therapy of Uncomplicated Gram-Negative Bacteremia?
por: McAlister, Michael, et al.
Publicado: (2019)

1211. Impact of Gram-Negative Rod Bacteremia Rapid Diagnostic Testing and Real-Time Clinical Staff Pharmacist Review
por: Kremer, Abby, et al.
Publicado: (2023)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
por: Ganapathiraju, Iaswarya, et al.
Publicado: (2020)

714 Gram Negative Bacteremia: Are Shorter Courses of Antimicrobial Therapy Feasible?
por: Swamy, Siddharth, et al.
Publicado: (2014)

192. Augmenting Utility of Rapid Diagnostic Testing in Treatment of Gram-Negative Bacteremia with Stewardship Intervention
por: Gerges, Jessica, et al.
Publicado: (2019)

1171. Impact of Catheter Management on the Clinical Outcome in Adult Cancer Patients with Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cphfviv68o62etc9q3vost9f6h